基于捕获法的产前游离DNA筛查用于常染色体隐性非综合征性耳聋
本研究开发并验证了一种基于捕获富集的产前游离DNA筛查方法,用于对常染色体隐性遗传病进行胎儿基因分型。在94对携带GJB2或SLC26A4变异的ARNSHL夫妇中,该方法对胎儿基因分型的准确率为81.9%(77/94),识别ARNSHL的敏感性为89.7%、特异性为89.2%。
要点
- 基于捕获的产前cfDNA筛查方法对94对ARNSHL携带者夫妇的胎儿基因分型准确率为81.9%(77/94)。
- 高置信度判读的150个SNP位点中139个(92.7%)与羊膜腔穿刺基因诊断一致。
- 该方法识别ARNSHL的敏感性为89.7%,特异性为89.2%。
核心结论
- 这种基于捕获的产前cfDNA筛查方法在常染色体隐性遗传病的胎儿基因分型方面展现出很大潜力。
研究设计与样本
- 本研究旨在开发并验证一种基于捕获富集的产前cfDNA筛查方法,对常染色体隐性遗传病进行胎儿基因分型,并应用于常染色体隐性非综合征性耳聋(ARNSHL)高风险妊娠以评估其准确性和有效性。
- 采用基于捕获的新一代测序方法,检测孕妇血样中白细胞DNA和cfDNA的等位基因计数,并应用二项模型以最大似然法推断胎儿基因型。
- 共纳入94对携带GJB2或SLC26A4变异的ARNSHL夫妇,将筛查方法推断的胎儿基因型与羊膜腔穿刺基因诊断结果进行比较。
主要发现
- 94对夫妇中65对携带一个以上变异,导致胎儿需推断170个单核苷酸多态性(SNP)位点。
- 170个胎儿SNP基因型中,150个(88.2%)为高置信度判读,其中139个(92.7%)与羊膜腔穿刺结果一致。
- 其余20个(11.8%)低置信度判读病例中,仅14个(70.0%)与羊膜腔穿刺基因诊断一致。
- 母体基因型为野生型纯合子的位点一致率为100%。
- 不一致具有位点偏向性,每个位点显示一致的不一致方向。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aimed to develop and validate a prenatal cell-free DNA (cfDNA) screening method that uses capture-based enrichment to genotype fetal autosomal recessive disorders. This method was applied in pregnancies at high risk of autosomal recessive non-syndromic hearing loss (ARNSHL) to assess its accuracy and effectiveness. METHODS: This assay measured the allele counts in both white blood cell DNA and cfDNA from the blood samples of pregnant women using a capture-based next-generation sequencing method. It then applied a binomial model to infer the fetal genotypes with the maximum likelihood. Ninety-four pregnant couples that were carriers of variants of ARNSHL in GJB2 or SLC26A4 were enrolled. The fetal genotypes deduced using this screening method were compared with the results of genetic diagnosis using amniocentesis. RESULTS: Of the 94 couples, 65 carried more than one variant, resulting in 170 single-nucleotide polymorphism (SNP) loci to be inferred in the fetuses. Of the 170 fetal SNP genotypes, 150 (88.2%) had high confidence calls and 139 (92.7%) of these matched the genotypes obtained by amniocentesis result. Out of the remaining 20 (11.8%) cases with low-confidence calls, only 14 (70.0%) were concordant with genetic diagnosis using amniocentesis. The concordance rate was 100% for sites where the maternal genotype was wild-type homozygous. The discordance was site-biased, with each locus showing a consistent direction of discordance. Genetic diagnosis identified a total of 19 wild-type homozygotes, 46 heterozygotes, 19 compound heterozygotes, and 10 pathogenic homozygotes. This screening method correctly genotyped 81.9% (77/94) of fetuses and demonstrated a sensitivity of 89.7% and a specificity of 89.2% for correctly identifying ARNSHL. CONCLUSION: This capture-based method of prenatal screening by cfDNA demonstrated strong potential for fetal genotyping of autosomal recessive disorders.
引用
- Mu Q, Bai L, Xu B, et al. A capture-based method of prenatal cell-free DNA screening for autosomal recessive non-syndromic hearing loss. Prenat Diagn. 2024. PMID: 38488843. doi:10.1002/pd.6550
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。